miR-145 supports cancer cell survival and shows association with DDR genes, methylation pattern, and epithelial to mesenchymal transition
| Autor: | Pawan K. Dhar, Siddharth Manvati, Ankita Arora, Sunil Kumar Saini, Kailash Chandra Mangalhara, Rupali Chopra, Rakesh Kumar, Rameshwar N. K. Bamezai, Usha Kumari, Gaurav Agarwal, Ponnuswamy Kalaiarasan, M.K. Kaushik |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Cancer Research
Vimentin Methylation lcsh:RC254-282 SMAD3 03 medical and health sciences 0302 clinical medicine Downregulation and upregulation Genetics Epithelial–mesenchymal transition DR5 lcsh:QH573-671 biology Oncogene lcsh:Cytology miR-145 lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens BRCA2 Oncology CpG site 030220 oncology & carcinogenesis DNA methylation Cancer cell Cancer research biology.protein Primary Research |
| Zdroj: | Cancer Cell International, Vol 19, Iss 1, Pp 1-12 (2019) Cancer Cell International |
| ISSN: | 1475-2867 |
| Popis: | Background Despite several reports describing the dual role of miR-145 as an oncogene and a tumor suppressor in cancer, not much has been resolved and understood. Method In this study, the potential targets of miR-145 were identified bio-informatically using different target prediction tools. The identified target genes were validated in vitro by dual luciferase assay. Wound healing and soft agar colony assay assessed cell proliferation and migration. miR-145 expression level was measured quantitatively by RT-PCR at different stages of breast tumor. Western blot was used to verify the role of miR-145 in EMT transition using key marker proteins. Result Wound healing and soft agar colony assays, using miR-145 over-expressing stably transfected MCF7 cells, unraveled its role as a pro-proliferation candidate in cancerous cells. The association between miR-145 over-expression and differential methylation patterns in representative target genes (DR5, BCL2, TP53, RNF8, TIP60, CHK2, and DCR2) supported the inference drawn. These in vitro observations were validated in a representative set of nodal positive tumors of stage 3 and 4 depicting higher miR-145 expression as compared to early stages. Further, the role of miR-145 in epithelial–mesenchymal (EMT) transition found support through the observation of two key markers, Vimentin and ALDL, where a positive correlation with Vimentin protein and a negative correlation with ALDL mRNA expression were observed. Conclusion Our results demonstrate miR-145 as a pro-cancerous candidate, evident from the phenotypes of aggressive cellular proliferation, epithelial to mesenchymal transition, hypermethylation of CpG sites in DDR and apoptotic genes and upregulation of miR-145 in later stages of tumor tissues. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |